Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating symptoms. Research shows extended Paxlovid treatment could help restore ...

A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

Patients are reporting difficulties accessing the anti-COVID drug Paxlovid this winter, even as the coronavirus causing the infectious disease reaches levels not seen in months. Angela Carpio couldn’t ...